A series of Phe-Gly dipeptide-derived piperazinones containing an aromatic urea moiety and a basic amino acid has been synthesized and evaluated as inhibitors of human platelet aggregation induced by the PAR1 agonist SFLLRN and as cytotoxic agents in human cancer cells. The synthetic strategy involves coupling of a protected basic amino acid benzyl amide to 1,2- and 1,2,4-substituted-piperazinone derivatives, through a carbonylmethyl group at the N1-position, followed by formation of an aromatic urea at the exocyclic moiety linked at the C2 position of the piperazine ring and removal of protecting groups. None of the compounds showed activity in the biological evaluation.
                                    我们合成了一系列由 Phe-Gly 二肽衍生的
哌嗪酮类化合物,其中含有一个芳香族
脲基和一个碱性
氨基酸,并将其作为 PAR1 激动剂 SFLLRN 诱导的人体血小板聚集的
抑制剂和人体癌细胞的细胞毒剂进行了评估。合成策略包括将受保护的碱性
氨基酸苄基酰胺通过 N1 位的羰基甲基与 1,2- 和 1,2,4- 取代的
哌嗪酮衍
生物偶联,然后在
哌嗪环 C2 位连接的外环分子上形成芳香族
脲,并去除保护基团。这些化合物都没有在
生物评估中显示出活性。